IFNGR2 and glioblastoma: In terms of interferons and receptors, IFNGR2 conferred sensitivity to T-cell mediated cytotoxic activity and enhanced the anti-tumor effectiveness of CD8+ T cells in vitro, while high expression of IFNB1 was associated with chemotherapy resistance and a poor prognosis in glioblastoma (36, 37).